THALIDOMIDE AND LOVASTATIN AS A SALVAGE IMMUNOMODULATORY THERAPY IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA

被引：0
|
作者：
Hus, M.
Adamczyk-Cioch, M. [1 ]
Jawniak, D. [1 ]
Grzasko, N. [1 ]
Morawska, M. [1 ]
Kozicka, J. [1 ]
Szostek, M. [2 ]
Helbig, G. [3 ]
机构：
[1] Med Univ, Dept Hematol & Bone Marrow Transplantat, Lublin, Poland
[2] Jagiellonian Univ, Coll Med, Dept Haematol, Krakow, Poland
[3] Silesian Med Univ, Katowice, Poland
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1445
引用
收藏
页码：577 / 577
页数：1
相关论文
共 50 条
  • [21] Efficacy of thalidomide therapy in patients with relapsed or refractory multiple myeloma: a meta-analysis
    Vardhan, Gyan
    Kumar, Vikas
    Sherawat, Amit
    Singh, Neha
    Dhamija, Puneet
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S192 - S192
  • [22] Thalidomide in the treatment of relapsed multiple myeloma
    Rajkumar, SV
    Fonseca, R
    Dispenzieri, A
    Lacy, MQ
    Lust, JA
    Witzig, TE
    Kyle, RA
    Gertz, MA
    Greipp, PR
    MAYO CLINIC PROCEEDINGS, 2000, 75 (09) : 897 - 901
  • [23] Salvage thalidomide improves survival of relapsed multiple myeloma patients when compared to other salvage chemotherapies: A retrospective analysis.
    Bahlis, NJ
    Savoie, L
    Chaudhry, A
    Valentine, K
    Jenkins, D
    Brown, C
    Russell, J
    Stewart, D
    BLOOD, 2005, 106 (11) : 369B - 369B
  • [24] Thalidomide salvage therapy following immunomodulatory treatment
    Streetly, M. J.
    Gyertson, K.
    Kazmi, M.
    Zeldis, J.
    Schey, S. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 168 - 168
  • [25] Rapid response and early relapse after thalidomide plus dexamethasone salvage therapy in patients with advanced relapsed and refractor multiple myeloma.
    Tosi, P
    Zamagni, E
    Cellini, C
    Cangini, D
    Tura, S
    Baccarani, M
    Cavo, M
    BLOOD, 2001, 98 (11) : 163A - 163A
  • [26] Low dose thalidomide in patients with relapsed or refractory multiple myeloma
    Kees, M
    Dimou, G
    Sillaber, C
    Drach, J
    Ackermann, J
    Lechner, K
    Gisslinger, H
    LEUKEMIA & LYMPHOMA, 2003, 44 (11) : 1943 - 1946
  • [27] The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma
    Grover, JK
    Uppal, G
    Raina, V
    ANNALS OF ONCOLOGY, 2002, 13 (10) : 1636 - 1640
  • [28] Combination Therapy with Thalidomide, Incadronate, and Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Naoya Ochiai
    Noriko Yamada
    Ryo Uchida
    Shin-ichi Fuchida
    Akira Okano
    Mayumi Hatsuse
    Masashi Okamoto
    Eishi Ashihara
    Chihiro Shimazaki
    International Journal of Hematology, 2005, 82 : 243 - 247
  • [29] Combination therapy with thalidomide, incadronate, and dexamethasone for relapsed or refractory multiple myeloma
    Ochiai, N
    Yamada, N
    Uchida, R
    Fuchida, S
    Okano, A
    Hatsuse, M
    Okamoto, M
    Ashihara, E
    Shimazaki, C
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (03) : 243 - 247
  • [30] Immunomodulatory analogues of thalidomide in the treatment of multiple myeloma
    Suppiah, Revathi
    Srkalovic, J. Gordan
    Hussein, Mohamad A.
    CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (04): : 301 - 305
12345